NFE2L2 and neoplasm: Any increase in NRF2 signaling would provide a pro-survival effect to the tumour by suppressing ROS levels, increasing NADPH and purine levels, inhibiting the recruitment of immune cells and increasing detoxification of common chemotherapeutics such as Cisplatin and Carboplatin.